Neuropathic Pain

Latest News

Perineural Injection of Platelet-Rich Plasma for Peripheral Neuropathy Pain

Perineural injection of platelet-rich plasma may improve pain and numbness associated with diabetic peripheral neuropathy, and enhance peripheral nerve function.

FDA Approves First Generics for Lyrica

The FDA has approved the first generics of Lyrica (pregabalin; Pfizer) capsules.

Addition of Gabapentin to Valacyclovir Does Not Improve Herpes Zoster Pain

The addition of gabapentin to valacyclovir within 72 hours of onset of a herpes zoster rash was not found to provide further relief from acute herpetic pain or to better prevent postherpetic neuralgia.

Diabetic Peripheral Neuropathy Associated With Increased Health Care Costs

Researchers found a substantial cohort of adults with diabetic peripheral neuropathy in the United States with high financial and social costs.

Group Acupuncture May Be Beneficial for Painful Diabetic Neuropathy

Group acupuncture may alleviate pain and improve quality of life in patients with painful diabetic neuropathy.

Treating CRPS-Associated Neuropathic Pain With EGF Receptor Inhibition

A single infusion of cetuximab was not associated with relief from therapy-resistant neuropathic pain.

Live-Attenuated Zoster Vaccine Reduces Herpes Zoster Pain and Neuralgia

Live-attenuated herpes zoster vaccine protects against postherpetic neuralgia even when [herpes zoster] occurs despite vaccination.

Neuropathic Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

For patients with chronic inflammatory demyelinating polyradiculoneuropathy, the presence of neuropathic pain leads to worsened disability and disease outcome.

Age Stratified CSF-TP Improves Diagnostic Specificity of CIDP

Updating the upper reference limits for CSF-TP according to age may aid in eliminating chances of misdiagnosing CIDP.

Noted Absence of IgM Monoclonal Gammopathy in Anti-MAG Neuropathy

The occurrence of anti-myelin-associated glycoprotein (MAG) without IgM monoclonal gammopathy is possible in patients with chronic inflammatory demyelinating polyradiculoneuropathy.